TSX-V: ELC
Home
Corporate
Directors & Officers
Corporate Directory
Investments
Overview
Shareholder Value
Track Record
Our Top Ten Investments
US Vanadium LLC
Investors
Financial Statements
Stock Information
Share Structure
Dividend History
Media Coverage
Related Websites
Annual General Meeting
Presentations
News
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Contact
Investors
Media Coverage
On the US Vanadium web site:
May 27, 2025
Tyfast and US Vanadium Sign an MOU to Industrially Scale a New Class of Metal Oxide Anode to Power Batteries in Heavy Duty Vehicles
September 28, 2023
Vanadium Industry Veteran Vincent Rocco Joins US Vanadium
February 24, 2022
U.S. Vanadium Expands Sales Agreement with CellCube for up to 3 Million Liters/Year of Ultra-High-Purity Vanadium Redox Flow Battery Electrolyte
On the BioAegis web site:
May 6, 2025
BioAegis Therapeutics Announces Site Activation and Patient Recruitment Underway in 13 Countries in Phase 2b Clinical Trial of Gelsolin, an Immune Regulator, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)
October 17, 2024
October 17, 2024: BioAegis Therapeutics Enrolls First Patient in Phase 2 Clinical Trial of Gelsolin, an Immune Regulator, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)
October 16, 2023
BioAegis Therapeutics Awarded $20 Million BARDA DRIVe Contract to Advance Gelsolin, an Immune Regulator, as a Treatment for Patients with Acute Respiratory Distress Syndrome (ARDS)
Financial Statements
Stock Information
Share Structure
Dividend History
Media Coverage
Related Websites
Annual General Meeting
Presentations
Home
Corporate
Directors & Officers
Corporate Directory
Investments
Overview
Shareholder Value
Track Record
Our Top Ten Investments
US Vanadium LLC
Investors
Financial Statements
Stock Information
Share Structure
Dividend History
Media Coverage
Related Websites
Annual General Meeting
Presentations
News
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Contact
Legal
RSS Feed
© 2025 Elysee Development Corp.
All rights reserved.